CLONIDINE 0.1 MG
CLONIDINE HYDROCHLORIDE : 0.1 MG · DIN 02361302 · SANIS HEALTH INC
Health Canada status: CANCELLED POST MARKET
What is CLONIDINE?
CLONIDINE 0.1 MG contains CLONIDINE HYDROCHLORIDE : 0.1 MG. It is listed in the Health Canada Drug Product Database under DIN 02361302, held by SANIS HEALTH INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02361302 |
|---|---|
| Brand name | CLONIDINE |
| Generic / active ingredient | CLONIDINE HYDROCHLORIDE : 0.1 MG |
| Manufacturer | SANIS HEALTH INC |
| Strength | 0.1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02AC01 CLONIDINE |
| AHFS class | 24:08.16 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2012 |
| Original market date | 2011-02-08 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C02AC01 CLONIDINE. 14 of 31 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLONIDINE | 0.025 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02540061 |
| CLONIDINE | 0.1 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02538490 |
| CLONIDINE | 0.2 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02538504 |
| JAMP CLONIDINE | 0.025 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02528207 |
| MAR-CLONIDINE | 0.025 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02524198 |
| MINT-CLONIDINE | 0.025 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02534738 |
| MINT-CLONIDINE | 0.1 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02462192 |
| MINT-CLONIDINE | 0.2 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02462206 |
| SANDOZ CLONIDINE | 0.025 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02516217 |
| SANDOZ CLONIDINE | 0.1 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02515784 |
Who else supplies CLONIDINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CLONIDINE appears in 41 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.